U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298252) titled 'Diagnostic Accuracy of Carebot AI MMG in Mammography Screening: Multicenter MRMC Study' on Nov. 14.
Brief Summary: This study evaluates the diagnostic performance of Carebot AI MMG, an artificial intelligence (AI)-enabled medical device for evaluating mammograms. The software analyzes standard full-field digital mammography (FFDM) images and classifies each examination as having no suspicious finding ("Low Risk"), a probably benign mass ("Medium Risk"), or a suspicious malignant mass ("High Risk").
The study is retrospective and observational. It uses anonymized mammography examinations from four screening centers, without any addi...